GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfx | mm39_v1_chrX_-_93166992_93167018 | 0.90 | 3.7e-14 | Click! |
Zfp711 | mm39_v1_chrX_+_111510223_111510223 | 0.62 | 5.3e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_74510413 Show fit | 12.05 |
ENSMUST00000100866.3
|
coiled-coil domain containing 92B |
|
chr4_+_156046745 Show fit | 10.64 |
ENSMUST00000024338.5
|
C1q and tumor necrosis factor related 12 |
|
chr7_-_37806912 Show fit | 10.35 |
ENSMUST00000108023.10
|
cyclin E1 |
|
chr14_-_70873385 Show fit | 9.74 |
ENSMUST00000228295.2
ENSMUST00000022695.16 |
dematin actin binding protein |
|
chr7_-_142211203 Show fit | 9.17 |
ENSMUST00000097936.9
ENSMUST00000000033.12 |
insulin-like growth factor 2 |
|
chr9_+_110848339 Show fit | 8.85 |
ENSMUST00000198884.5
ENSMUST00000196777.5 ENSMUST00000196209.5 ENSMUST00000035077.8 ENSMUST00000196122.3 |
lactotransferrin |
|
chrX_+_72683020 Show fit | 8.59 |
ENSMUST00000019701.9
|
dual specificity phosphatase 9 |
|
chr10_+_79722081 Show fit | 7.74 |
ENSMUST00000046091.7
|
elastase, neutrophil expressed |
|
chr15_+_89218601 Show fit | 7.20 |
ENSMUST00000023282.9
|
myo-inositol oxygenase |
|
chr15_+_73596602 Show fit | 7.14 |
ENSMUST00000230177.2
ENSMUST00000163582.9 |
protein tyrosine phosphatase 4a3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 64.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.4 | 29.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.8 | 29.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
4.0 | 24.2 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.9 | 22.4 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.5 | 18.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.5 | 17.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.5 | 17.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 17.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.3 | 15.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 60.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.6 | 45.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 36.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 36.2 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 34.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 30.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 25.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 25.1 | GO:0000776 | kinetochore(GO:0000776) |
3.5 | 24.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 24.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 223.3 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 76.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.5 | 41.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 37.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.9 | 34.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 33.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.7 | 31.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 23.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 21.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 20.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 45.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.5 | 31.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 27.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 27.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 23.6 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 23.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 22.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 20.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 18.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 18.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 65.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 52.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 48.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 34.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 33.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 29.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.5 | 27.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 27.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.6 | 26.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
1.7 | 22.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |